{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:43:46Z","timestamp":1761662626613},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.clinthera.2008.04.020","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T08:54:58Z","timestamp":1213433698000},"page":"964-973","source":"Crossref","is-referenced-by-count":25,"title":["Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"30","author":[{"given":"Warren","family":"Schonfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wang Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo B.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raafat","family":"Seifeldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.04.020_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1524-4733.2002.51108.x","article-title":"The direct cost and incidence of systemic fungal infections","volume":"5","author":"Wilson","year":"2002","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2008.04.020_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-143-12-200512200-00004","article-title":"Empirical anti-Candida therapy among selected patients in the intensive care unit: A cost-effectiveness analysis","volume":"143","author":"Golan","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2008.04.020_bib3","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1378\/chest.121.6.1988","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"121","author":"Soubani","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2008.04.020_bib4","first-page":"696","article-title":"for the Infectious Diseases Society of America","volume":"30","author":"Stevens","year":"2000","journal-title":"Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2008.04.020_bib5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/23.3.608","article-title":"Therapeutic outcome in invasive aspergillosis","volume":"23","author":"Denning","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2008.04.020_bib6","unstructured":"Tong KB, Lau CL, Murtagh K, et al, The economic impact of aspergillosis: Analysis of hospital expenditures across patient subgroups. Int J Infect Dis. In press."},{"key":"10.1016\/j.clinthera.2008.04.020_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.04.020_bib8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, doubleblind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2008.04.020_bib9","first-page":"1407","article-title":"for the National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"39","author":"van Burik","year":"2004","journal-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2008.04.020_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1592\/phco.27.1.53","article-title":"Micafungin: A new echinocandin antifungal","volume":"27","author":"Joseph","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2008.04.020_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/14787210.4.3.457","article-title":"Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: Current issues and new agents","volume":"4","author":"Strasfeld","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.clinthera.2008.04.020_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12185-007-0011-1","article-title":"Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation","volume":"87","author":"Hashino","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clinthera.2008.04.020_bib13","unstructured":"Bureau of Labor Statistics, US Dept of Labor, Consumer Price Index-All Urban Consumers, US City Average, Hospital and Related Services [BLS Web site]. http:\/\/www.bls.gov\/cpi\/home.htm. Accessed February 14, 2006."},{"key":"10.1016\/j.clinthera.2008.04.020_bib14","series-title":"Red Book","year":"2006"},{"key":"10.1016\/j.clinthera.2008.04.020_bib15","first-page":"2476","article-title":"Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients [published correction appears in J Clin Oncol","volume":"18","author":"Cagnoni","year":"2000","journal-title":"2000;18:3064]. J Clin Oncol"},{"key":"10.1016\/j.clinthera.2008.04.020_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0272989X9801800312","article-title":"Uncertainty in decision models analyzing costeffectiveness: The joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method","volume":"18","author":"Hunink","year":"1998","journal-title":"Med Decis Making"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808001707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808001707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T21:53:55Z","timestamp":1545947635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808001707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0149291808001707"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.04.020","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}